We identified one tumor with BCL2L14–ETV6 associated with mesenchymal TNBC39 and another with ETV6–NTRK3 that was a marker of secretory breast carcinoma, a rare basal-like breast cancer40,41. Here, BCL2L14 is linked to neoplasm.